Videos

Opexa Therapeutics, Inc. (NASDAQ: OPXA)

Neil Warma of Opexa Therapeutics talks to Equities.com about the personalized cellular therapies to treat multiple sclerosis (MS) based on its proprietary T-cell technology that his company is focused on.

Comments